Dusa Pharmaceuticals, Inc. (DUSA) Tops Q3 EPS by 5c
Tweet
Share
E-mailGet Alerts DUSA Hot Sheet
Price: $57.15 +0.14%
Financial Fact:
INCOME (LOSS) FROM OPERATIONS: 273.34K
Today's EPS Names:
EGRX, VAXX, AFIB, More
Financial Fact:
INCOME (LOSS) FROM OPERATIONS: 273.34K
Today's EPS Names:
EGRX, VAXX, AFIB, More
Join SI Premium – FREE
Dusa Pharmaceuticals, Inc. (NASDAQ: DUSA) reported Q3 EPS of $0.05, $0.05 better than the analyst estimate of $0.00. Revenue for the quarter came in at $9.4 million versus the consensus estimate of $8.79 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Abercrombie & Fitch (ANF) Tops Q2 EPS by $2.19, Offers Guidance
- Semtech (SMTC) Tops Q2 EPS by 10c, Beats on Revenue; Offers Q3 Guidance
- Bath & Body Works, Inc. (BBWI) Tops Q2 EPS by 38c, Offers FY27 EPS Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
